Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
31.17
-0.53 (-1.67%)
At close: Nov 4, 2024, 4:00 PM
32.00
+0.83 (2.66%)
Pre-market: Nov 5, 2024, 5:35 AM EST
Immunocore Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 280.91 | 249.43 | 174.36 | 36.48 | 30.11 | 25.67 | Upgrade
|
| Revenue | 280.91 | 249.43 | 174.36 | 36.48 | 30.11 | 25.67 | Upgrade
|
| Revenue Growth (YoY) | 27.95% | 43.05% | 377.91% | 21.15% | 17.32% | 8.52% | Upgrade
|
| Cost of Revenue | 199.77 | 164.58 | 103.01 | 100.25 | 74.81 | 99.99 | Upgrade
|
| Gross Profit | 81.14 | 84.85 | 71.35 | -63.76 | -44.7 | -74.32 | Upgrade
|
| Selling, General & Admin | 154.84 | 144.5 | 123.06 | 110.82 | 45.74 | 44.18 | Upgrade
|
| Other Operating Expenses | 0.9 | 0.9 | -0.01 | 0.07 | -1.61 | -0.19 | Upgrade
|
| Operating Expenses | 155.74 | 145.39 | 123.05 | 110.9 | 44.13 | 44 | Upgrade
|
| Operating Income | -74.6 | -60.55 | -51.7 | -174.66 | -88.83 | -118.32 | Upgrade
|
| Interest Expense | -10.15 | -5.15 | -5.41 | -5.57 | -3.11 | -3.8 | Upgrade
|
| Interest & Investment Income | 25.07 | 17.99 | 3.76 | 0.07 | 0.71 | 1.4 | Upgrade
|
| Currency Exchange Gain (Loss) | -4.2 | -13.18 | 14.16 | 0.29 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 4.76 | - | - | - | 1.24 | -5.47 | Upgrade
|
| EBT Excluding Unusual Items | -59.12 | -60.89 | -39.2 | -179.88 | -90 | -126.19 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -1.06 | - | Upgrade
|
| Other Unusual Items | - | - | -1.69 | - | 3.7 | - | Upgrade
|
| Pretax Income | -59.12 | -60.89 | -40.88 | -179.88 | -87.36 | -126.19 | Upgrade
|
| Income Tax Expense | -4.24 | -5.6 | 11.66 | 0.15 | -13.27 | -22.26 | Upgrade
|
| Net Income | -54.88 | -55.29 | -52.54 | -180.03 | -74.09 | -103.93 | Upgrade
|
| Net Income to Common | -54.88 | -55.29 | -52.54 | -180.03 | -74.09 | -103.93 | Upgrade
|
| Shares Outstanding (Basic) | 50 | 49 | 46 | 42 | 27 | 22 | Upgrade
|
| Shares Outstanding (Diluted) | 50 | 49 | 46 | 42 | 27 | 22 | Upgrade
|
| Shares Change (YoY) | 3.45% | 6.94% | 7.59% | 60.19% | 18.95% | 3.43% | Upgrade
|
| EPS (Basic) | -1.11 | -1.13 | -1.15 | -4.24 | -2.79 | -4.66 | Upgrade
|
| EPS (Diluted) | -1.11 | -1.13 | -1.15 | -4.24 | -2.79 | -4.66 | Upgrade
|
| Free Cash Flow | 9.45 | -2.49 | -51.41 | -144.49 | -64.32 | -106.98 | Upgrade
|
| Free Cash Flow Per Share | 0.19 | -0.05 | -1.12 | -3.40 | -2.43 | -4.80 | Upgrade
|
| Gross Margin | 28.88% | 34.02% | 40.92% | -174.77% | -148.42% | -289.54% | Upgrade
|
| Operating Margin | -26.56% | -24.27% | -29.65% | -478.73% | -294.98% | -460.95% | Upgrade
|
| Profit Margin | -19.53% | -22.17% | -30.13% | -493.45% | -246.04% | -404.89% | Upgrade
|
| Free Cash Flow Margin | 3.36% | -1.00% | -29.49% | -396.04% | -213.60% | -416.76% | Upgrade
|
| EBITDA | -70.49 | -56.46 | -46.37 | -167.07 | -82.38 | -111.56 | Upgrade
|
| EBITDA Margin | -25.09% | -22.63% | -26.59% | - | -273.57% | - | Upgrade
|
| D&A For EBITDA | 4.11 | 4.09 | 5.34 | 7.59 | 6.45 | 6.76 | Upgrade
|
| EBIT | -74.6 | -60.55 | -51.7 | -174.66 | -88.83 | -118.32 | Upgrade
|
| EBIT Margin | -26.56% | -24.27% | -29.65% | - | -294.98% | - | Upgrade
|
| Revenue as Reported | 280.91 | 249.43 | 174.36 | 36.48 | 30.11 | 25.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.